Roscovitine

A novel regulator of P/Q-type calcium channels and transmitter release in central neurons

Zhen Yan, Ping Chi, James A. Bibb, Timothy A. Ryan, Paul Greengard

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Roscovitine is widely used for inhibition of cdk5, a cyclin-depenpent kinase expressed predominantly in the brain. A novel function of roscovitine, i.e. an effect on Ca2+ channels and transmitter release in central neurons, was studied by whole-cell voltage-clamp recordings and time-lapse fluorescence imaging techniques. Extracellular application of roscovitine markedly enhanced the tail calcium current following repolarization from depolarized voltages. This effect was rapid, reversible and dose dependent. Roscovitine dramatically slowed the deactivation kinetics of calcium channels. The deactivation time constant was increased 3- to 6-fold, suggesting that roscovitine could prolong the channel open state and increase the calcium influx. The potentiation of tail calcium currents caused by roscovitine and by the L-channel activator Bay K 8644 was not occluded but additive. Roscovitine-induced potentiation of tail calcium currents was significantly blocked by the P/Q-channel blocker CgTx-MVIIC, indicating that the major target of roscovitine is the P/Q-type calcium channel. In mutant mice with targeted deletion of p35, a neuronal specific activator of cdk5, roscovitine regulated calcium currents in a manner similar to that observed in wild-type mice. Moreover, intracellular perfusion of roscovitine failed to modulate calcium currents. These results suggest that roscovitine acts on extracellular site(s) of calcium channels via a cdk5-independent mechanism. Roscovitine potentiated glutamate release at presynaptic terminals of cultured hippocampal neurons detected with the vesicle trafficking dye FM1-43, consistent with the positive effect of roscovitine on the P/Q-type calcium channel, the major mediator of action potential-evoked transmitter release in the mammalian CNS.

Original languageEnglish (US)
Pages (from-to)761-770
Number of pages10
JournalJournal of Physiology
Volume540
Issue number3
DOIs
StatePublished - May 1 2002

Fingerprint

Q-Type Calcium Channels
P-Type Calcium Channels
Neurons
Calcium
Tail
Calcium Channels
roscovitine
Time-Lapse Imaging
3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
Cyclins
Optical Imaging
Presynaptic Terminals

ASJC Scopus subject areas

  • Physiology

Cite this

Roscovitine : A novel regulator of P/Q-type calcium channels and transmitter release in central neurons. / Yan, Zhen; Chi, Ping; Bibb, James A.; Ryan, Timothy A.; Greengard, Paul.

In: Journal of Physiology, Vol. 540, No. 3, 01.05.2002, p. 761-770.

Research output: Contribution to journalArticle

Yan, Zhen ; Chi, Ping ; Bibb, James A. ; Ryan, Timothy A. ; Greengard, Paul. / Roscovitine : A novel regulator of P/Q-type calcium channels and transmitter release in central neurons. In: Journal of Physiology. 2002 ; Vol. 540, No. 3. pp. 761-770.
@article{6b8cf5e4261d4e0d8fa40f8d2aed4b34,
title = "Roscovitine: A novel regulator of P/Q-type calcium channels and transmitter release in central neurons",
abstract = "Roscovitine is widely used for inhibition of cdk5, a cyclin-depenpent kinase expressed predominantly in the brain. A novel function of roscovitine, i.e. an effect on Ca2+ channels and transmitter release in central neurons, was studied by whole-cell voltage-clamp recordings and time-lapse fluorescence imaging techniques. Extracellular application of roscovitine markedly enhanced the tail calcium current following repolarization from depolarized voltages. This effect was rapid, reversible and dose dependent. Roscovitine dramatically slowed the deactivation kinetics of calcium channels. The deactivation time constant was increased 3- to 6-fold, suggesting that roscovitine could prolong the channel open state and increase the calcium influx. The potentiation of tail calcium currents caused by roscovitine and by the L-channel activator Bay K 8644 was not occluded but additive. Roscovitine-induced potentiation of tail calcium currents was significantly blocked by the P/Q-channel blocker CgTx-MVIIC, indicating that the major target of roscovitine is the P/Q-type calcium channel. In mutant mice with targeted deletion of p35, a neuronal specific activator of cdk5, roscovitine regulated calcium currents in a manner similar to that observed in wild-type mice. Moreover, intracellular perfusion of roscovitine failed to modulate calcium currents. These results suggest that roscovitine acts on extracellular site(s) of calcium channels via a cdk5-independent mechanism. Roscovitine potentiated glutamate release at presynaptic terminals of cultured hippocampal neurons detected with the vesicle trafficking dye FM1-43, consistent with the positive effect of roscovitine on the P/Q-type calcium channel, the major mediator of action potential-evoked transmitter release in the mammalian CNS.",
author = "Zhen Yan and Ping Chi and Bibb, {James A.} and Ryan, {Timothy A.} and Paul Greengard",
year = "2002",
month = "5",
day = "1",
doi = "10.1113/jphysiol.2001.013376",
language = "English (US)",
volume = "540",
pages = "761--770",
journal = "Journal of Physiology",
issn = "0022-3751",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Roscovitine

T2 - A novel regulator of P/Q-type calcium channels and transmitter release in central neurons

AU - Yan, Zhen

AU - Chi, Ping

AU - Bibb, James A.

AU - Ryan, Timothy A.

AU - Greengard, Paul

PY - 2002/5/1

Y1 - 2002/5/1

N2 - Roscovitine is widely used for inhibition of cdk5, a cyclin-depenpent kinase expressed predominantly in the brain. A novel function of roscovitine, i.e. an effect on Ca2+ channels and transmitter release in central neurons, was studied by whole-cell voltage-clamp recordings and time-lapse fluorescence imaging techniques. Extracellular application of roscovitine markedly enhanced the tail calcium current following repolarization from depolarized voltages. This effect was rapid, reversible and dose dependent. Roscovitine dramatically slowed the deactivation kinetics of calcium channels. The deactivation time constant was increased 3- to 6-fold, suggesting that roscovitine could prolong the channel open state and increase the calcium influx. The potentiation of tail calcium currents caused by roscovitine and by the L-channel activator Bay K 8644 was not occluded but additive. Roscovitine-induced potentiation of tail calcium currents was significantly blocked by the P/Q-channel blocker CgTx-MVIIC, indicating that the major target of roscovitine is the P/Q-type calcium channel. In mutant mice with targeted deletion of p35, a neuronal specific activator of cdk5, roscovitine regulated calcium currents in a manner similar to that observed in wild-type mice. Moreover, intracellular perfusion of roscovitine failed to modulate calcium currents. These results suggest that roscovitine acts on extracellular site(s) of calcium channels via a cdk5-independent mechanism. Roscovitine potentiated glutamate release at presynaptic terminals of cultured hippocampal neurons detected with the vesicle trafficking dye FM1-43, consistent with the positive effect of roscovitine on the P/Q-type calcium channel, the major mediator of action potential-evoked transmitter release in the mammalian CNS.

AB - Roscovitine is widely used for inhibition of cdk5, a cyclin-depenpent kinase expressed predominantly in the brain. A novel function of roscovitine, i.e. an effect on Ca2+ channels and transmitter release in central neurons, was studied by whole-cell voltage-clamp recordings and time-lapse fluorescence imaging techniques. Extracellular application of roscovitine markedly enhanced the tail calcium current following repolarization from depolarized voltages. This effect was rapid, reversible and dose dependent. Roscovitine dramatically slowed the deactivation kinetics of calcium channels. The deactivation time constant was increased 3- to 6-fold, suggesting that roscovitine could prolong the channel open state and increase the calcium influx. The potentiation of tail calcium currents caused by roscovitine and by the L-channel activator Bay K 8644 was not occluded but additive. Roscovitine-induced potentiation of tail calcium currents was significantly blocked by the P/Q-channel blocker CgTx-MVIIC, indicating that the major target of roscovitine is the P/Q-type calcium channel. In mutant mice with targeted deletion of p35, a neuronal specific activator of cdk5, roscovitine regulated calcium currents in a manner similar to that observed in wild-type mice. Moreover, intracellular perfusion of roscovitine failed to modulate calcium currents. These results suggest that roscovitine acts on extracellular site(s) of calcium channels via a cdk5-independent mechanism. Roscovitine potentiated glutamate release at presynaptic terminals of cultured hippocampal neurons detected with the vesicle trafficking dye FM1-43, consistent with the positive effect of roscovitine on the P/Q-type calcium channel, the major mediator of action potential-evoked transmitter release in the mammalian CNS.

UR - http://www.scopus.com/inward/record.url?scp=0036588343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036588343&partnerID=8YFLogxK

U2 - 10.1113/jphysiol.2001.013376

DO - 10.1113/jphysiol.2001.013376

M3 - Article

VL - 540

SP - 761

EP - 770

JO - Journal of Physiology

JF - Journal of Physiology

SN - 0022-3751

IS - 3

ER -